Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Schond L Greenway Insider Profile
4 Followers
Schond L Greenway, Chief Financial Officer at Mind Medicine, holds 32.18K shares in Mind Medicine (Ticker: MNMD).
Schond L Greenway Mind Medicine (MNMD)Chief Financial Officer
Mind Medicine (MNMD)
Chief Financial Officer
Ranked #92,189 out of 98,496 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-52.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Schond L Greenway's holdings
Insider Roles
Chief Financial Officer
Roles that Schond L Greenway holds in companies
Most Profitable Insider Trade
The most profitable trade made by Schond L Greenway
Schond L Greenway's Trading History
List of latest transactions for each holding click on a transaction to see Schond L Greenway's performance on stock
You May Also Like
Schond L Greenway insider profile FAQ
What is the percentage of profitable transactions made by Schond L Greenway?
The percentage of profitable transactions made by Schond L Greenway is 20%.
What is the average return per transaction made by Schond L Greenway?
The average return per transaction made by Schond L Greenway is -52.50%.
What stocks does Schond L Greenway hold?
Schond L Greenway holds: MNMD stocks.
What was Schond L Greenway’s latest transaction?
Schond L Greenway latest transaction was an Uninformative Sell of ―.
What was Schond L Greenway's most profitable transaction?
Schond L Greenway’s most profitable transaction was an Informative Sell of MNMD stock on March 26, 2024. The return on the trade was 38.90%.
What is Schond L Greenway's role in Mind Medicine?
Schond L Greenway's role in Mind Medicine is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.